FDA Approves First Pill to Treat Moderate-to-Severe Crohn's Disease

FRIDAY, May 19, 2023 -- Patients with Crohn’s disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).
Rinvoq is meant to treat adults with moderately to severely active...